Pure Global
NCT06325202

Closed Loop and Education for Hypoglycemia Awareness Restoration

Closed Loop and Education for Hypoglycemia Awareness Restoration (CLEAR), Conducted by the Impaired Awareness of Hypoglycemia Consortium (IAHC)
Milton S. Hershey Medical Center·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Mellitus, Type 1
Drug/Device/Intervention
Omnipod 5 or Medtronic 780G
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Milton S. Hershey Medical Center
Location
La Jolla,Orlando,Lexington,Minneapolis,Philadelphia,Fitzroy,Leicester,Sheffield, Australia,United Kingdom,United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2024
End date
Dec 31, 2027
Enrollment
324 participants
Primary outcome

epinephrine (pg/ml),Towler questionnaire

Summary

The purpose of the CLEAR study is to determine the effect on counterregulatory responses
 (CRR) of intervening (by attempting to strictly avoid hypoglycemia) to improve awareness of
 hypoglycemic symptoms among adults with type 1 diabetes (T1D) who have impaired awareness of
 hypoglycemia (IAH). IAH affects 20-25% of adults with T1D, and rises with increasing duration
 of T1D.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06325202
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06325202 through Pure Global AI's free database. This phase not specified trial is sponsored by Milton S. Hershey Medical Center and is currently Not yet recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 324 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.